RiteshRathoreMD
Oncology • Providence, RIGastrointestinal Cancer, Head & Neck Cancer, Hematologic Oncology, Thoracic Cancer
Associate Professor, Medicine, Boston University School of Medicine
Dr. Rathore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Chalkstone Ave
Providence, RI 02908Phone+1 401-456-2077Fax+1 401-456-5765
Education & Training
Brown UniversityFellowship, Hematology and Medical Oncology, 1997 - 2000
Maimonides Medical CenterResidency, Internal Medicine, 1994 - 1997
Delhi University- University College of Medical SciencesClass of 1991, MBBS
Certifications & Licensure
RI State Medical License 2000 - 2026- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 126 citationsOverexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma.Howard Safran, Margaret M. Steinhoff, Shamlal Mangray, Ritesh Rathore, Thomas King
American Journal of Clinical Oncology. 2001-10-01 - 77 citationsTargeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical TrialLawrence G. Lum, Archana Thakur, Zaid Al-Kadhimi, Gerald A. Colvin, Francis J. Cummings
Clinical Cancer Research. 2015-02-16 - 22 citationsMultiple infusions of CD20-targeted T cells and low-dose IL-2 after SCT for high-risk non-Hodgkin's lymphoma: A pilot studyLawrence G. Lum, Archana Thakur, Cassara Pray, Nicola Kouttab, Mehrdad Abedi
Bone Marrow Transplantation. 2014-01-01
Press Mentions
TriSalus Life Sciences : And Roger Williams Medical Center Announce Initiation of Phase 1 Clinical Trial for a Novel Delivery Technology That Can Enhance Drug Delivery into Pancreatic TumorsFebruary 12th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
